Cargando…
Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma
Rhabdoid tumors (RT) are highly aggressive and vastly unresponsive embryonal tumors. They are the most common malignant CNS tumors in infants below 6 months of age. Medulloblastomas (MB) are embryonal tumors that arise in the cerebellum and are the most frequent pediatric malignant brain tumors. Des...
Autores principales: | Sredni, Simone Treiger, Bailey, Anders W., Suri, Amreena, Hashizume, Rintaro, He, Xingyao, Louis, Nundia, Gokirmak, Tufan, Piper, David R., Watterson, Daniel M., Tomita, Tadanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762315/ https://www.ncbi.nlm.nih.gov/pubmed/29340047 http://dx.doi.org/10.18632/oncotarget.22704 |
Ejemplares similares
-
Polo-Like Kinase 4 (PLK4) Is Overexpressed in Central Nervous System Neuroblastoma (CNS-NB)
por: Bailey, Anders W., et al.
Publicado: (2018) -
Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer
por: Suri, Amreena, et al.
Publicado: (2019) -
Rhabdoid Tumor: Gene Expression Clues to Pathogenesis and Potential Therapeutic Targets
por: Gadd, Samantha, et al.
Publicado: (2010) -
Role of Polo-like Kinases Plk1 and Plk4 in the Initiation of Centriole Duplication—Impact on Cancer
por: Hoffmann, Ingrid
Publicado: (2022) -
STIL binding to Polo-box 3 of PLK4 regulates centriole duplication
por: Arquint, Christian, et al.
Publicado: (2015)